Hingge joined Fidelity Biosciences as a Venture Partner in April 2009. Most recently he was a Managing Director at Lehman Brothers in their Private Equity Group, responsible for their principal investment activities in the private and public sectors of the healthcare industry. Prior to that, he was a Partner at Schroder Ventures Life Sciences from 1998 to 2001 and directed their US investment activities in the life sciences and therapeutics sectors. Hingge was also a Principal at Robertson Stephens in the Healthcare Investment Banking Group and worked at Chiron Corporation and Gensia, Inc in the areas of business development and strategic planning. Hingge received an MD degree from Yale University School of Medicine and was trained in internal medicine at Brigham and Women's Hospital and Harvard Medical School. He also received an MBA degree from Harvard Business School.

Dr. Hsu serves on the Board of Directors of NextWave Pharmaceuticals.